This study aims to quantify the MT and CEST parameters in glioblastoma at 1.5T over four time points of chemoradiation. Previous approaches to quantify the MT/CEST signal in terms of response to treatment were at higher field strengths. Additionally, we analyzed different subregions within the clinical target volume and gross tumor volume, generated by thresholding based on the T1-weighted, FLAIR and DWI scans, for comparing the MT/CEST parameters between the early and late tumor progression. Results indicated that MT/CEST at 1.5T can be used for monitoring therapy and that the results depend on the specific tumor region analyzed.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords